<DOC>
	<DOCNO>NCT00042458</DOCNO>
	<brief_summary>This randomize , triple-blind , placebo-controlled , multicenter study investigate safety pramlintide treatment use pramlintide dose-titration couple insulin adjustment subject type 1 diabetes actively try improve glycemic control .</brief_summary>
	<brief_title>Evaluation Dose-titration Pramlintide During Initiation Therapy Patients Trying Improve Glucose Control</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Pramlintide</mesh_term>
	<mesh_term>Islet Amyloid Polypeptide</mesh_term>
	<criteria>HbA1c value 7.59 % Using multiple daily insulin injection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>